Diagnostic accuracy of transesophageal echocardiogram for the detection of patent foramen ovale: a meta-analysis. by Mojadidi, Mohammad Khalid et al.
UCLA
UCLA Previously Published Works
Title
Diagnostic accuracy of transesophageal echocardiogram for the detection of patent 
foramen ovale: a meta-analysis.
Permalink
https://escholarship.org/uc/item/6475b67z
Journal
Echocardiography (Mount Kisco, N.Y.), 31(6)
ISSN
0742-2822
Authors
Mojadidi, Mohammad Khalid
Bogush, Nikolay
Caceres, Jose Diego
et al.
Publication Date
2014-07-01
DOI
10.1111/echo.12462
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
1-
©2013, Wiley Periodicals, Inc.
DOI:10.1111/echo.12462 Echocardiography
Diagnostic Accuracy of Transesophageal 
Echocardiogram for the Detection of Patent
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Background: Patent foramen ovale (PFO) is a remnant of the fetal circulation present
in 20% of the population. Right-to-left shunting (RLS) through a PFO has been linked
to  the  pathophysiology  of   stroke,  migraine with  aura,  and hypoxemia.  While
different imaging modalities including transcranial Doppler, intra-cardiac echo, and
transthoracic echo (TTE) have often been used to detect RLS, trans- esophageal echo
(TEE) bubble study remains the gold standard for diagnosing PFO. The aim of this
study was to determine the relative accuracy of TEE in the detection of PFO. Methods
and Results: A sys- tematic review of Medline, using a standard approach for meta-
analysis, was performed for all prospec- tive studies assessing accuracy of TEE in the
detection  of  PFO  using  conﬁrmation  by  autopsy,  cardiac  surgery,  and/or
catheterization  as  the  reference.  Search  results  revealed  3105  studies;  4  met
inclusion  criteria.  A  total  of  164  patients  were  included.  TEE  had  a  weighted
sensitivity of 89.2% (95% CI: 81.1–94.7%) and speciﬁcity of 91.4% (95% CI: 82.3–
96.8%) to detect  PFO.  The  overall  positive  likelihood ratio (LR+) was 5.93 (95%
CI: 1.30–27.09) and the  overall  negative  likelihood  ratio  (LR  )  was  0.22 (95% CI:
0.08–0.56).  Conclusion:  While  TEE  bubble  study is  considered to   be  the   gold
standard   modality  for  diagnosing  PFO,  some  PFOs  may  still  be  missed  or
misdiagnosed. It is important to understand the limitations of TEE and perhaps use
other  highly  sensitive  screening  tests,  such  as  trans-  cranial  doppler  (TCD),  in
conjunction  with  TEE  before  scheduling  a  patient  for  transcatheter  PFO  closure.
(Echocardiography2014;31:752–758)
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Background:
Patent  foramen  ovale  (PFO)  is  a
remnant of the fetal circulation present
in  15–35%  of  the  general  population
based  on  autopsy  and  imaging  stud-
ies.1–4While  most  people  with  a  PFO
remain  asymptomatic,  some  develop
medical syndromes that can be chronic
and  debilitating.  Transient  right-to-left
shunting (RLS), usually  through  a PFO,
has currently been linked to cryptogenic
stroke,  migraine  with  aura,  acephalgic
migraine,  sleep  apnea,  platypnea-
orthodeoxia,  and  decom-  pression
illness.5–8A  meta-analysis  of  observa-
tional  studies  and  the  combined  data
from the CLOSURE 1, RESPECT, and PC
Trials  suggest  that  PFO  occluding
devices reduce the recurrence of
Address  for  correspondence  and  reprint  requests:Moham-mad
Khalid  Mojadidi,  MD,  Department  of  Medicine,AlbertEinstein
College of Medicine, Jacobi Medical Center, 1400Pel-ham Parkway
South Building 1, Rm 3N1, Bronx,  NY10461.Fax:718-904-4169;
E-mail:mkmojadidi@gmail.com
2stroke  and  transient
ischemic  attack  at  higher
rates  than  conventional
medicaltreatmentalone
(pooled  HR   0.59,   95%
CI    0.36–0.97;  P=0.04).9–
11Thisdataalongwiththeanticip
ated results  of  the PREMIUM
trial—a  double-blinded
sham-controlled  study  to
evaluate  the  effect  of
PFOclosureinpatientswithmi
graineheadaches(Gov.Trials
#NCT00355056)—have
made  it
essentialtoaccuratelydiagno
sePFOforpatients
beingconsideredfortranscathet
erclosure.
Transesophageal  echo
(TEE)  with  agitatedsal-ine
bubble study is  considered
by  some  authors   as  the
best technique available for
the  diagnosis  of
PFO.12,13Other  commonly
used  imaging  modalities
include  transthoracic  echo
(TTE)withor  without
harmonic
imaging,14transcranial
doppler  (TCD),15and  intra-
cardiac  echo.16TEE  is  often
used as  the  reference test
whencomparingthe
sensitivities  and
speciﬁcities  of  these
modali-  ties.  It  is  thus
important  to  understand
the diag- nostic accuracy of
TEE  for  the  detection
ofP F O .
Mojadidi, et 
al.
The  purpose  of  this  meta-analysis
wastodetermine the accuracy of TEE for
the   diagnosis  of  PFO.  TEE  was
compared   with   PFO   detection  by
autopsy,  cardiac  surgery  and/or
septalprob-ing during catheterization as
the gold standard reference.
Methods:
Search Strategy:
RelevantcitationsweresearchedforonPub
Medusingtheterms“‘PFO’OR‘patentfora
menovale’OR‘right  to  left
shunt’AND‘transesophageal
echo’OR‘echo’OR‘echocardiography’O
R‘transesophageal echocardiogram’.”
The references of all of the retrieved
primary studies as well as those of other
knownpriorreviews  were  manually
searched  toﬁndcitedarticles  that  were
not  found by  the  database search.  No
restrictions  were  used  regarding
publication  language.  Other
methodological  searchﬁlters  were  not
applied.17Abstracts   lacking  peer-
reviewed  manuscripts  wereomit-ted  as
they  would  not  have
enoughdatarequired  for  the  meta-
analysis  (i.e.  true  positive  [TP],  true
negative  [TN],  false  positive[FP],false
negative  [FN]).  The  search   was
completed  in  February  2013,  covering
published literature since1956 .
Selection Criteria:
Articles  that  were  identiﬁed  were
analyzedbytw o  i ndepen den t
rev ie we rs  (N .  B .  and  J .
D . C.).Disagreements  between  the  two
reviewersweresettled by consensus with
a  third  reviewer  (M.K.M.).  Each  article
was  screened  for  preset  inclusion
criteria:
1) Original  prospective  studies
(retrospective  studies,  reviews,
abstracts,
isolatedcases,commentaries,
editorials,  and
letters)wereexcluded.
2) Studies  were  selected  for  the
review  iftheyincluded  at  least  20
patients  withsuspectedPFO  who
were  screened  by
contrastTEEbubble  study  and
conﬁrmed  by  cardiac
catheterization,  autopsy  and/or
intra-surgi- cal conﬁrmation as the
referencetests.
3) Provided the TP,  TN,  FP, and FN
results of the contrast TEE bubble
study,  thusallow-
ingthecalculationofsensitivity,speciﬁci
ty,  positivelikelihoodratios,andnegativelike-
lihoodratios(LR+andLR-).
Statistical Analyses:
Analyses  were  conducted  using  the  Meta-DiSc
software  (Version  1.4).18Potential  variations  due  to
threshold effect were assessed graphically by
Accuracy of TEE for 
diagnosing PFOvisual  inspection  of
accuracy estimates pairs in
forest  plots  and  summary
receiver  operating
characteristic  (sROC)
curves  as  well  as
statistically  by  computing
the  spearman
correlationcoefﬁ-cient
between  the  logit  of
sensitivity  and  the  logit  of
1-speciﬁcity.18,19To  assess
between-study  het-
erogeneity  (other  than
threshold
effect)andbetween-study
inconsistency,  the
CochranQstatistic,  and
the  inconsistency
index  ( I 2) were calculated,
respectively,  and  the  level
ofs i g n i ﬁ-  cance  for  the
corresponding  P-value  was
setatP=0.10.  Due  to
anticipated  inter-study
hetero-  geneity,  a  random
effects  analysis  model
(DerSi-  monian–Laird)20was
used for this meta-analysis
because  it  provides  more
conservative  estimates  of
the pooled data. sROC were
constructed  using  the
DerSimonian–Laird  random
effectsmodel.The  area
under the curve (AUC) and
indexQ*were used to assess
and  summarize  the
discrimi-  nating  ability  of
the sROC curve.21To assess
the  stability  of  the
diagnostic accuracy results,
one-way sensitivity analysis
was  performedbyomitting
every study (one at a time)
fromthemeta-analysis.
Values  of  95%
conﬁdenceintervals(CI)
were  used  for  all  pooled
data;  all  P  valuesaretwo
tailed  and  a  P-value
of<0.05  was  considered
statistically  signiﬁcant
unless  where  otherwise
speciﬁed.
Quality Assessment:
The  quality  of  each  study
was  evaluated  bydeter-
mining 14 items considered
relevant  tothereview  topic,
based  on  the  Quality
AssessmentofDiagnostic
Accuracy Studies (QUADAS)
instru- ment.22
Results:
Characteristics of Studies:
Of  the  11  potential  studies
identiﬁed,16,23–324  prospective  studies
comprising  164  patientsmetthe
inclusion  criteria  and  formed  the
dataset.29–32Figure  1  describes  the
study  selection  method  used  for
thisanalysis.
QualityAssessment:
Using  the  recommended  14-item
checklistforevaluating imaging studies
using QUADAS,items2, 5, 8, 9, and 11
either  were  scored
poorlyorwereconsideredunclear:item2(“se
lectioncrite-  ria  described?”),  item  5
(“partial  veriﬁcation  avoided?”),  item
8  (“index  test  described  in
detailtopermitreplication?”),item9(“refer
ence  standard  described  in  detail  to
permit  replica-  tion?”),  and  item  11
(“reference  standardresults  blinded?”).
When  assessing  for  selection  criteria
(i.e. item 2), one study failed to clearly
deﬁne  their  inclusion  criteria  when
selectingpartici-
pants.Regardingitem5whichisused
toavoid
Figure 1.Selection of studies.
selection  bias,  in  2  studies  not  all
participants  underwent  the  reference
standard  test.  Inbothof  these  studies,
this was not inﬂuenced bytheindex test
nor  did  they  include  these
patientsintheﬁnal  analysis.  With  regard
to  items  8  and  9,  one  study  did  not
provide  a  detailed  description  of  the
diagnostic  procedures  which  can
increase  the  variability  in  the  test’s
performance.  Item11refers  to  blinding
and  may  affect  diagnosticaccu-racy
leading  to  potential  review  bias;
inonestudy,  it  was  not  clear  if  the
reference  test  results  were  blinded.
Otherwise,  all  studiesdemon-strated
high-quality  scoring  on  the
remaining9items (Fig.2 ) .
TEE Diagnostic Value:
Table  I  describes  the  characteristics  oftheincluded
studies and Table II summarizestheaccuracies of the
studies. When all eligiblestudies
--
were  pooled  into  the
diagnostic  accuracy  meta-
analysis,  the  overall
sensitivity  of  TEEforPFO
detection was 89.2%  (95%
CI:   81.1–94.7%; I2=65.9%;
Fig.  3A),  the  overall
speciﬁcity was 91.4% (95%
CI:  82.3–96.8%;
I2=7 2 . 2 % ;
Fig. 3B), the overall 
LR+was 5.93 (95% CI: 
1.30–27.09; I2=80.3%; Fig.
3C), and the overall LR 
was  0.22  (95%  CI:  0.08–
0.56;  I2=37.3%;   Fig.3D).
The  included  studies
were  signiﬁcantly  heter-
ogenous  in  their  estimates
of  sensitivity,speciﬁc-ity,
LR+(Q  statistic  P
values<0.1)  with  the
exception of LR  (Q  statistic
P=0.19).  Thresh- old effect
was  not  signiﬁcant
(spearman  r=0.6;P=0.4).
The sROC curve is shown in
Figure4.The  pooled  AUC
and  index  Q*were
0.93(95%CI:0.83–
1.0)and0.86(95%CI:0.75–
0.98),
respectively (Fig. 4). The 
stability of ourmodelwas  
conﬁrmed  by  the  leave-
one-outsensitivity
Figure 2.Methodological Quality Table.
TABLE I
Characteristics of the Included
Studies
First Author
(Year)
N
Mal
e(
%)
Contra
st 
Used?
Site 
of 
Injectio
n
Bubbl
e
Studi
es
PerTE
E
Provocation
Maneuver
(Valsalva/Ot
her)
Calculatio
nsDone
duringPro
vocation?
Micro-
Embolic
Threshold
for  Positive
TEE
Chenetal. 32
(1992)30
Schneider 35
53%
57%
Yes
Yes
NS
Anticubital 
or
3
3–6
Valsalvamaneuver
Valsalvamaneuver
Yes
Yes
≥5Mb
≥1Mb
et al. 
(1996)31Spenc
er
56 56% Yes
central 
line 
Anticubital
≥2 Valsalva 
maneuver
Yes ≥1 Mb
et al. 
(2004)32Augo
ustides
et al. 
(2004)29
4177%Yes Central 
lineinto
superior 
vena cava
NS Mechanically
ventilated,  at
end-expiration
and at releaseof
25 cm H2O RPAP
Yes (most pts)≥1 Mb
Mb=microbubbles; TEE=transesophageal echocardiogram; RPAP=Release of positive airway pressure; NS=not speciﬁed.
TABLE II
Accuracies of the Included
Studies
First Author (Year) Sensitivity (95% 
CI)
Speciﬁcity (95% 
CI)
P-LR (95% CI) N-LR (95%
CI)
Chen et al. (1992)30 1.00 (0.82–1.00) 0.92 (0.64–1.00) 9.10 (2.00–
41.35)
0.03 (0.00–
0.43)
Schneider et al. 
(1996)31
0.89 (0.52–1.00) 1.00 (0.86–1.00) 44.20 (2.80–
696.51)
0.15 (0.03–
0.67)
Spencer et al. (2004)32 0.91 (0.79–0.97) 0.33 (0.01–0.91) 1.36 (0.61–3.04) 0.28 (0.05–
-1.72)
Augoustides et al. 
(2004)29
0.67 (0.35–0.90) 0.90 (0.73–0.98) 6.44 (2.05–
20.23)
0.37 (0.17–
0.84)
P-LR=positive likelihood ratio; N-LR=negative likelihood ratio; CI=conﬁdence interval.
analysis  which  generated  pooled
estimates close to those obtained with
all  eligible  studies  (mean  sensitivity
89.0%, range 86.5–92.6%; mean
speciﬁcity 91.2%,  range 86.7–94.0%;  meanLR+
6.2,  range  3.96–8.73;meanLR 0.21,range
0.14–0.30).
Figure 3.Diagnostic  accuracy forest plots.  Forest plots of  the overall  sensitivityA. speciﬁcityB. positive
likelihood ratioC. and negative likelihood ratioD. of PFO detection by TEE are presented. The size of each
square is proportional to sample size. The hori- zontal lines in each square show the corresponding 95%
conﬁdence intervals (CI). The center of the diamond indicates the overall sensitivity, speciﬁcity, positive
likelihood,  and negative likelihood ratios,  respectively, and the  ends  correspond  to  the  95%  CI.
PFO=patent foramen ovale; TEE=transesophagealechocardiogram.
Figure  4.Summary  receiver  operating
characteristic  (SROC)  curves.  Individual  study
estimates  of  sensitivity  and  1–speci-ﬁcity  are
represented by the circles. Circle sizes are propor-
tional to study weights. The lateral lines represent
95% conﬁdence intervals.
Discussion:
When  evaluating  patients  for  a  PFO,
several imaging modalities are available
to  determine  whether  a  right-to-left
shunt is  present.Theseinclude TTE with
or  without  harmonic  imaging,  TCD,
intra-cardiac  echo,  and  TEE.
Whileeachmethod  has  its  beneﬁts  and
limitations,TEEremains  the  best
performing test availablefordiagnosing a
PFO  due  to  its  minimal  invasiveness,
safety  proﬁle  and  ability  to  accurately
visualize the atrial septal anatomy.12,13In
addition,  TEE  is  superior  to  other
modalities  for  the
detectionandmeasurement  of  atrial
septalaneurysms.33
Some studies have shown similar sensitivities for 
PFO detection when comparing TTE with
second  harmonic  imaging
to  TEE.34–36However,  the
high sensitivity of TTE with
harmonicimag-ing  is  often
accompanied  by  a  lower
relative speciﬁcity, whereas
TEE can more accuratelydif-
ferentiate  between  a  PFO
and  pulmonaryarte-
riovenous
malformation.37Standard
TTE  is  often  limited  in  its
ability  to  detect  smaller
shunts.TTEonly detects 50–
60%  of  PFOs
whencomparedwith  TEE.38–
40The  beneﬁts   of   TTE
include   its   low  cost,
noninvasiveness,  and  easy
availability.  TCD  is
commonly  used  as  a
screening  testfordetection
of PFO. Compared with TEE,
the  sensi-  tivity  of  TCD
ranges  between
68and100%.15,38,41–
47Although  the   sensitivity
of  TCD  is higher than that
of  standard   TTE,
TCDdoesnot  directly
visualize  the  atrial  septum
and  thus  cannot
differentiate   between   a
PFO   andanASD  or  intra-
pulmonary  shunt  which
limitsitsspeciﬁcity.
This  study  is  theﬁrst
meta-analysis  to  investi-
gate the accuracy of TEE in
PFO  detectioncom-pared
with
conﬁrmatoryﬁndingsbycath
eterization,  autopsy  and/or
cardiac  surgery.  While
these  modalities  may  be
the  ultimategoldstandard
for PFO detection, it  would
be impracti-  cal  to  subject
every  patient  with  a
suspected  PFO  to
catheterization  or  surgery,
let  aloneanautopsy.
Therefore,  each  method
ofconﬁrmingthe presence of
a  PFO  has  inherent  biases
astoappropriate  subjects
who  would  be
included.TEEis a much less
invasive test that is widely
consid- ered to be the most
reasonable
benchmarkforPFO
diagnosis.  The  imperfect
accuracy
ofTEEdemonstrated  in  this
article  may  be
explainedbytechnical  limitations
including patient intolerance for the TEE
probe,  difﬁculty  performing  an  ade-
quate Valsalva maneuver with a probe
inthe
esophagus, variations in 
patients’anatomy, and operator 
experience.36
Our observation is also limited by the
small  number  of  studies available  that
comparetheaccuracy  of  TEE  for  the
detection  of  PFO  tocath-eterization,
autopsy  and/or  surgicalﬁndings.The164
patients  that  encompassed  the
studypopu-lation were either severely ill,
referred  for  PFOclo-  sure  for  PFO-related
conditions,  or  hadothercardiac  diseases
which  required  surgery.Thiscohort  may
have been different from the majority of
other  studies  that  often  include
patientswhounderwent  TEE  after  being
referred  foreitherrecurrent  stroke
ormigraines.
In conclusion, our data demonstrates
TEEtohave  a  sensitivity  of  0.89  and
speciﬁcity  of0.91for  the  diagnosis  of
PFO. The low negative likeli- hood ratio
of  TEE  suggests  that  it  is  a  proﬁcient
test of exclusion forPFO.
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